Buprenorphine Induction and Naloxone Distribution Program-Combined With Warm Hand-Off Referral to Continued Treatment
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 65
- 试验地点
- 1
- 主要终点
- Patient Focused: Number of patients receiving services.
研究概览
简要总结
This study is a collaboration between the University of Utah and Castleview Hospital in Price, Utah.
Buprenorphine is a medication approved by the FDA to treat Opioid Use Disorder (OUD). Castleview Hospital currently does not prescribe buprenorphine in the emergency department (ED) instead it refers patients to outside addiction treatment facilities. This is a service focused project which the University of Utah will provide mentoring and education to Castleview in implementing an in ED buprenorphine/naloxone distribution program along with referral to continued services. After the program has been implemented, the investigators will evaluate it using quantitative surveys of program participants and qualitative interviews of hospital staff and stakeholders.
详细描述
Among health care environments, ED often are the front lines of care for those with OUD or who experience opioid overdose.
The University of Utah Hospital ED has the Bridge Program which provides buprenorphine and naloxone with warm-hand off referral for continued treatment to people presenting with OUD. In order to extend the services offered by the Bridge Program to rural hospitals, the investigators will be providing mentoring and education to Castleview Hospital in establishing a similar program. Castleview Hospital is the only acute care hospital that serves Carbon and Emery counties, which outside of the Salt Lake City metro area have the highest opioid overdose rates in the State of Utah.
This project will utilize both quantitative and qualitative measures to evaluate the impact of this program on patients, hospital staff, and community members.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •For qualitative interviews with providers, administrators, stakeholders:
- •Must be affiliated with Castleview Hospital as a provider, administrator or stakeholder.
- •For the quantitative surveys:
- •Must be a Castleview Hospital patient who receives the BINDeR-Tx model.
排除标准
- •For qualitative interviews with providers, administrators, stakeholders:
- •Not familiar with the BINDeR-Tx model
- •No interaction with the BINDeR-Tx model
- •For the quantitative surveys:
- •Unable to speak and read English
- •Subject is unable to provide contact information
结局指标
主要结局
Patient Focused: Number of patients receiving services.
时间窗: 24 months
Will be the aggregate number of individuals who received ED-initiated buprenorphine.
次要结局
- Living Conditions(enrollment and 6 months post enrollment)
- Mental and Physical Health Problems and Treatment/Recovery(enrollment and 6 months post enrollment)
- Implementation and service quality: Satisfaction with projected service(24 months.)
- Substance use diagnosis and treatment(enrollment and 6 months post enrollment)
- Social Connectedness(enrollment and 6 months post enrollment)
- Implementation and service quality: Patient satisfaction(enrollment and 6 months post enrollment)
- Discharge status(enrollment and 6 months post enrollment)
- Follow-up Status(enrollment and 6 months post enrollment)
- Legal Status(enrollment and 6 months post enrollment)
- Education, Employment, and Income(enrollment and 6 months post enrollment)
研究者
Jerry Cochran
Associate Professor
University of Utah